The aging process and psychoactive drug abuse PDF Download

Author: National Institute on Drug Abuse. Services Research Branch
Publisher:
ISBN:
Category :
Languages : en
Pages : 104

View

Book Description

Author: National Institute on Drug Abuse. Services Research Branch
Publisher:
ISBN:
Category : Older people
Languages : en
Pages : 0

View

Book Description

Author: National Institute on Drug Abuse. Services Research Branch
Publisher:
ISBN:
Category : Drugs and the aged
Languages : en
Pages : 104

View

Book Description

Author: National Institute on Drug Abuse
Publisher:
ISBN:
Category :
Languages : en
Pages : 50

View

Book Description

Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

View

Book Description

Author: Frederic C. Blow
Publisher: DIANE Publishing
ISBN: 0788180711
Category :
Languages : en
Pages : 198

View

Book Description
Researchers are only beginning to realize the pervasiveness of substance abuse, such as alcohol and prescription drug misuse, among older people, thousands of whom need treatment but do not receive it. This Treatment Improvement Protocol (TIP) recommends best practices for identifying, screening, assessing, and treating alcohol and prescription drug abuse among people age 60 and older. Sections: alcohol; use and abuse of psychoactive prescription drugs and OTC medications; identification, screening, and assessment; referral and treatment approaches; outcomes and cost issues; legal and ethical issues; tools. Bibliography. 19 charts and tables.

Author: Peter A. Bamberger
Publisher: Oxford University Press
ISBN: 0199374147
Category : Psychology
Languages : en
Pages : 177

View

Book Description
Evidence from both local and national surveys suggests that substance misuse and abuse among older adults in the United States is a "hidden epidemic" that poses a major threat to the welfare and quality of life of older drinkers and their families, and has significant public health implications. Based on their findings from a 10-year, NIH-funded study of retirement, aging, and substance misuse, Peter Bamberger and Samuel Bacharach examine the complex web of factors contributing to the precipitation and exacerbation of substance problems among older adults. They discuss the individual and public health implications of such problems, as well as some of the evidence-based steps that may be taken to prevent their emergence and help those in need of assistance for policy-makers and health practitioners. This book provides a single-source review of the latest research assessing the magnitude and costs of older-adult substance abuse, as well as detailed analysis of the epidemiology of older-adult substance abuse. The authors provide an analysis of the efficacy of alternative prevention and treatment strategies, and present scientific evidence in a user-friendly format, highlighting extensive interview data to accompany their statistical results. The illustrations offered by these real life cases not only provide a sense of richness and understanding to a complex issue, but also offer a fitting reminder to the reader that this is an issue affecting people we know and families like our own.

Author:
Publisher:
ISBN:
Category : Chemotherapy
Languages : en
Pages : 40

View

Book Description

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309439124
Category : Social Science
Languages : en
Pages : 171

View

Book Description
Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309453070
Category : Science
Languages : en
Pages : 487

View

Book Description
Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.